| CASE REPORT |
|
| Year : 2015 | Volume
: 5
| Issue : 2 | Page : 99-102 |
|
|
Ocular adnexal lymphoma: Five case reports and a literature review
Chui-Lien Tsen1, Muh-Chiou Lin1, Youn-Shen Bee1, Jiunn-Liang Chen1, Ni-Wen Kuo1, Shwu-Jiuan Sheu2
1 Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
2 Department of Ophthalmology, Kaohsiung Veterans General Hospital; School of Medicine, National Yang-Ming University, Taipei, Taiwan
Correspondence Address:
Muh-Chiou Lin
Department of Ophthalmology, Kaohsiung Veterans General Hospital, 386, Ta-Chung 1st Road, Kaohsiung 813, Taiwan
Taiwan
 Source of Support: None, Conflict of Interest: None
DOI: 10.1016/j.tjo.2014.05.007
|
|
|
This article reports the clinical course and treatment of ocular adnexal lymphoma based on a retrospective review of five cases with a histologically approved ocular adnexal lymphoma at Kaohsiung Veterans General Hospital over 10 years. Extranodal B-cell lymphoma in the orbit, lacrimal gland, eyelid, or conjunctiva was found in these patients. Four of them were female, and they were aged 45–64 years. All patients were also consulted with hematologists for possible systemic involvement and therapeutic plan. The patient with retrobulbar and orbital apex involvement received systemic chemotherapy. The patient with lacrimal gland involvement experienced tumor recurrence after local excision, and therefore received adjuvant radiotherapy. The remaining three patients had localized lymphoma on the eyelid or bulbar conjunctiva, and they all showed no recurrence after surgical excision. The incidence of ocular adnexal lymphoma has risen worldwide over the last few decades. Although most cases are confined to ocular adnexal, some may also be associated with disseminated lymphoma. Accurate diagnosis and staging is mandatory for appropriate treatment. Generally speaking, localized and low-grade ocular adnexal lymphoma involved eyelid or conjunctiva seem to have good outcome after surgical excision only. Systemic chemotherapy should be considered in patients with advanced disease or systemic manifestations, and radiotherapy also offers a good choice for lacrimal gland lymphoma.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
